- Home
- BLNK vs MGTX Comparison
BLNK vs MGTX Comparison
Compare BLNK & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- MGTX
- Stock Information
- Founded
- BLNK 2009
- MGTX 2015
- Country
- BLNK United States
- MGTX United States
- Employees
- BLNK N/A
- MGTX 372
- Industry
- BLNK Industrial Specialties
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLNK Consumer Discretionary
- MGTX Health Care
- Exchange
- BLNK Nasdaq
- MGTX Nasdaq
- Market Cap
- BLNK 77.3M
- MGTX 524.0M
- IPO Year
- BLNK N/A
- MGTX N/A
- Fundamental
- Price
- BLNK $0.97
- MGTX $7.60
- Analyst Decision
- BLNK Buy
- MGTX Strong Buy
- Analyst Count
- BLNK 8
- MGTX 2
- Target Price
- BLNK $2.61
- MGTX $24.00
- AVG Volume (30 Days)
- BLNK 4.3M
- MGTX 460.2K
- Earning Date
- BLNK 08-06-2025
- MGTX 08-11-2025
- Dividend Yield
- BLNK N/A
- MGTX N/A
- EPS Growth
- BLNK N/A
- MGTX N/A
- EPS
- BLNK N/A
- MGTX N/A
- Revenue
- BLNK $109,383,000.00
- MGTX $34,508,000.00
- Revenue This Year
- BLNK N/A
- MGTX $365.04
- Revenue Next Year
- BLNK $31.15
- MGTX $73.18
- P/E Ratio
- BLNK N/A
- MGTX N/A
- Revenue Growth
- BLNK N/A
- MGTX 203.23
- 52 Week Low
- BLNK $0.63
- MGTX $3.85
- 52 Week High
- BLNK $3.75
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- BLNK 57.30
- MGTX 71.28
- Support Level
- BLNK $0.86
- MGTX $6.31
- Resistance Level
- BLNK $0.98
- MGTX $6.80
- Average True Range (ATR)
- BLNK 0.08
- MGTX 0.38
- MACD
- BLNK 0.00
- MGTX 0.07
- Stochastic Oscillator
- BLNK 65.92
- MGTX 97.96
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.